FindTrial
Sign In

hUC-MSCs

BIOLOGICAL5 trials

Sponsors

Yang Yang, Chinese Academy of Sciences, Wuhan Central Hospital, Institute of Hematology & Blood Diseases Hospital, China, Shanghai East Hospital

Conditions

Diabetic Peripheral Neuropathy Type 2Erectile DysfunctionHuman Papillomavirus VirusesIschemic-type Biliary LesionsMesenchymal Stem CellsType 1 Diabetes MellitusType 2 Diabetes MellitusaGVHD

Phase 1

Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes
NCT02745808
Chinese Academy of SciencesErectile Dysfunction, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Start: 2015-09-30End: 2020-12-31Target: 30Updated: 2019-01-25
Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy
NCT05507697
Wuhan Central HospitalDiabetic Peripheral Neuropathy Type 2
Start: 2022-05-19End: 2024-05-31Target: 42Updated: 2022-08-19
HUC-MSC for Treatment of High-risk HPV Infection
RecruitingNCT06610773
Shanghai East HospitalHuman Papillomavirus Viruses, Mesenchymal Stem Cells
Start: 2024-03-01End: 2026-09-10Target: 60Updated: 2024-09-24

Phase 2

Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions
NCT02223897
Yang YangIschemic-type Biliary Lesions
Start: 2014-07-31End: 2018-06-30Target: 66Updated: 2014-08-22

Unknown Phase

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease
NCT05531266
Institute of Hematology & Blood Diseases Hospital, ChinaaGVHD
Start: 2022-09-01End: 2025-03-01Target: 182Updated: 2022-09-07